Suven Pharmaceuticals (SUVENPHAR.NSE) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
2
2.53
3.06
3.59

Details

Expected EPS
N/A
Actual EPS
2.1151889681999996
Surprise EPS
2.12
Surprise Percent
+∞%

Description

Suven Pharmaceuticals (SUVENPHAR.NSE) has reported earnings of 2.1151889681999996 per share for Q4 2024.

0 Comments

Share your thoughts